144 related articles for article (PubMed ID: 3481507)
21. CA-125 in gynecological malignancies.
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of CA125 as a circulating tumor marker for ovarian cancer.
Kuzuya K; Nozaki M; Chihara T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):949-57. PubMed ID: 3461071
[TBL] [Abstract][Full Text] [Related]
23. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
[TBL] [Abstract][Full Text] [Related]
25. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of CA-125 in patients with endometriosis.
Giudice LC; Jacobs AJ; Bell CE; Lippmann L
Gynecol Oncol; 1986 Oct; 25(2):256-8. PubMed ID: 3463522
[No Abstract] [Full Text] [Related]
27. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
[TBL] [Abstract][Full Text] [Related]
28. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
[TBL] [Abstract][Full Text] [Related]
29. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian cancer with diffuse vascular thrombosis. Endocardial, arterial and venous involvement. Disseminated intravascular coagulation with cryofibrinogen].
Michel D; Tommasi M; Favre-Gilly J; Faivre J; Schott B
Nouv Presse Med; 1972 Nov; 1(41):2753-8. PubMed ID: 4641475
[No Abstract] [Full Text] [Related]
31. A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumor-associated antigen OCA.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1980 Dec; 138(8):1222-3. PubMed ID: 7446632
[No Abstract] [Full Text] [Related]
32. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
[No Abstract] [Full Text] [Related]
33. Significance of multiparameter flow cytometric analysis of ovarian cancer.
Fowler WC; Maddock MB; Moore DH; Haskill S
Am J Obstet Gynecol; 1988 Apr; 158(4):838-45. PubMed ID: 3163230
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of CA125 and its assessment with an enzyme immunoassay.
Shi QY; Sakawaki T; Kasamatsu T; Ohkura H
Asia Oceania J Obstet Gynaecol; 1987 Sep; 13(3):325-33. PubMed ID: 3325003
[No Abstract] [Full Text] [Related]
36. CA-125 serum level in the diagnosis of pelvic masses: comparison with other methods.
Maggino T; Sopracordevole F; Matarese M; Di Pasquale C; Tambuscio G
Eur J Gynaecol Oncol; 1987; 8(6):590-5. PubMed ID: 3319631
[TBL] [Abstract][Full Text] [Related]
37. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
38. Elevated CA 125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes.
Finkler NJ; Kapnick SJ; Griffiths CT; Knapp RC
Gynecol Oncol; 1988 Mar; 29(3):356-60. PubMed ID: 3162223
[TBL] [Abstract][Full Text] [Related]
39. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
40. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
